Discussion of human papillomavirus prophylactic vaccination
DOI:
https://doi.org/10.1344/rbd2019.0.25048Keywords:
HPV, vaccination, vaccines, cancer, cervical cancer, infection, ethicsAbstract
In this article, the problem surrounding human papillomavirus—which causes some cancers, among which cervical cancer is the most prominent— and the prophylactic vaccination against it is addressed. First, the most relevant facts about both the virus and the vaccines are described. Second, the problems of the efficacy and safety of the vaccines are discussed. Third, two ethical problems of HPV vaccination are discussed: should it be obligatory or optional? Should it target only women or men too? I conclude with a call to extend HPV vaccination and HPV education in particular, and vaccination education in general.References
[1] Adams, S.: “Now teenage boys will be vaccinated against HPV which causes the deaths of hundreds of men every year”, Daily Mail, 22 de julio de 2018. [En línea]. Disponible en: https://www.dailymail.co.uk/news/article-5978713/Teenage-boys-vaccinated-against-HPV-causes-deaths-hundreds-men-year.html. [Último acceso: 10 octubre 2018].
[2] Centros para el Control y la Prevención de Enfermedades (CDC): ¿Cuántos cánceres están vinculados con el VPH cada año?, 2018. [En línea]. Disponible en: https://www.cdc.gov/spanish/cancer/hpv/statistics/cases.htm. [Último acceso: 3 de octubre 2018].
[3] Cervantes, J.L., Doan, A.H.: “Discrepancies in the evaluation of the safety of the human papillomavirus vaccine”, Mem Inst Oswaldo Cruz, vol. 113(8), 2018, e180063. Doi: 10.1590/0074-02760180063
[4] Chueke Perles, D.: “La vacuna contra el VPH ya es gratuita y obligatoria para varones de 11 años”, El País, 31 de enero de 2017. [En línea]. Disponible en: https://www.lanacion.com.ar/1979614-la-vacuna-contra-el-hpv-ya-es-gratuita-y-obligatoria-para-varones-de-11-anos. [Última consulta: 10 octubre 2015].
[5] Dare, T.: “Mass immunisation programmes: some philosophical issues”, Bioethics, vol. 12(2), 1998, 125-149.
[6] Dawson, A.: “The determination of the best interests in relation to childhood immunization”, Bioethics, vol. 19(1), 2005, 72-89.
[7] Dawson, A.: “Herd Protection as a Public Good: Vaccination and our Obligations to Others”, en A. Dawson y M. Verweij (Eds.) Ethics, Prevention, and Public Health, Oxford University Press, 2007, 160-178.
[8] De Martel, C., Plummer, M., Vignat, J., Franceschi, S.: “Worldwide burden of cancer attributable to HPV by site, country and HPV type”, International Journal of Cancer, vol. 141(4), 2017, 664-670.
[9] De Vincenzo, R., Conte, C., Ricci, C., Scambia, G., Capelli, G.: “Long-term efficacy and safety of human papillomavirus vaccination”, International Journal of Women´s Health, 6, 2014, 999-1010.
[10] Holland, S.: “Immunization”, Public Health Ethics, Polity Press, Cambridge, 2015, 186-210.
[11] Instituto Nacional del Cáncer (INC): “VPH y el cáncer”, 2015. [En línea] Disponible en: https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/germenes-infecciosos/hoja-informativa-vph#q4. [Último acceso: 3 de octubre 2018].
[12] Instituto Nacional del Cáncer: “Vacunas contra VPH (virus del papiloma humano)”, 2018. [En línea]. Disponible en: https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/germenes-infecciosos/hoja-informativa-vacuna-vph. [Última consulta: 3 de octubre 2018].
[13] Jamrozik, E., Handfield, T., Selgelid, M.J.: “Victims, vectors and villains: are those who opt out of vaccination morally responsible for the deaths of others?”, J Med Ethics, 42, 2016, 762-768.
[14] Kass, N.E.: “An Ethics Framework for Public Health”, American Journal of Public Health, vol. 91(11), 2001, 1776-1782.
[15] Lee, L., Garland, S.M.: “Human papillomavirus vaccination: the population impact”, F1000research, vol. 6, 2017, p. 866. doi:10.12688/f1000research.10691.1
[16] Lo, N. C., Hotez, P. J.: “Public health and economic consequences of vaccine hesitancy for measles in the United States”, JAMA Pediatrics, 171(9), 2017, 887-892.
[17] Mill, J.S. On Liberty, 1859, Introduction.
[18] Nicol, A.F., Andrade, C.V., Russomano, F.B., Rodrigues, L.L.S., Oliveira, N.S., Provance Jr., D.W.: “HPV vaccines: a controversial issue?, Brazilian Journal of Medical and Biological Research, vol. 49(5), 2016, e5060.
[19] Organización Panamericana de la Salud (OPS): “Cáncer Cervicouterino”, 2018. [En línea]. Disponible en: https://www.paho.org/hq/index.php?option=com_content&view=article&id=5420:2011-cervical-cancer&Itemid=3637&lang=es. [Último acceso: 3 de octubre 2018].
[20] Plotkin, S.L., Plotkin, S.A.: “A short history of vaccination”, en S.A. Poltkin, W. Orenstein y P.A. Offit (Eds.) Vaccines, 6 Edición, Elsevier Saunders, 2012, 1-13.
[21] Salazar Fajardo, L. J., Benavides Delgado, M. R., Boogaard, S., Marín, Y.: “Estrategias latinoamericanas para la vacunación contra el virus del papiloma humano – una revisión temática”, Hacia la promoción de la salud, vol. 22(2), 2017, 129-143.
[22] Schiller, J.T., Castellsagué, X., Garland, S.M.: “A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines”, Vaccine, vol. 30(5), 2012, F123-F138.
[23] Skeate, J.G., Woodham, A.W., Einstein, M.H., da Silva, D.M., Kast, W.M.: “Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases”, Human Vaccination Immunotherapy, vol. 12(6), 2016, 1418-1429.
[24] Stanley, M.: “HPV vaccination in boys and men”, Human Vaccines and Immunotherapeutics, Vol. 10(7), 2014, 2109-2111.
[25] Tabakman, R.: “El fracaso de la aplicación de la vacuna contra el virus del papiloma humano en Latinoamérica, Medscape, 2017. [En línea]. Disponible en: http://www.fasgo.org.ar/images/Fracaso_HPV.pdf. [Último acceso: 10 octubre 2018].
[26] World Health Organization (WHO): Guide to Introducing HPV Vaccine into National Immunization Programmes, WHO Press, Geneva, 2016.
[27] WHO: “Human papillomavirus vaccines: WHO position paper, May 2017 – recommendations”, Vaccine, vol. 35(43), 2017, 5753-5755.
[28] WHO: “Weekly epidemiological record”, WHO Press, año 92 (19), 2017, 241-268.
[29] WHO: “Safety update of HPV vaccines, 2017”. [En línea]. Disponible en: http://www.who.int/vaccine_safety/committee/topics/hpv/June_2017/en/. [Último acceso: 13 octubre 2018].
[30] WHO: “Immunization coverage”. [En línea]. Disponible en: http://www.who.int/mediacentre/factsheets/fs378/en/. [Último acceso: 13 octubre 2018].
Downloads
Published
How to Cite
Issue
Section
License
The author retains the copyright and grants Revista de Bioética y Derecho the right of first publication of the article. All articles published in Revista de Bioética y Derecho are under Creative Commons licensing Recognition – Non Commercial – NoDerivedArtwork (by-nc-nd 4.0), which allows sharing the content with third parties, provided that they acknowledge its authorship, initial publication in this journal and the terms of the license. No commercial use of the original work or generation of derivative works is permitted.
